Novo CEO pressed by Senate to chop charges of weight problems, diabetic issues medicines CEO Lars Fruergaard Jørgensen advised lawmakers the corporate would look at new talks with insurers with regards to the record charges of Wegovy and copyright if they pledge to help keep the medicines on their own https://archerasokb.blazingblog.com/30725789/details-fiction-and-healthcare-news